Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia.: Final report of the Polish Adult Leukemia Group (PALG CLL1)

被引:0
作者
Robak, T
Blonski, JZ
Kasznicki, M
Góra-Tybor, J
Dmoszynska, A
Wojtaszko, M
Skotnicki, AB
Nowak, W
Hellmann, A
Lewandowski, K
Zdziarska, B
Konopka, L
Ceglarek, B
Dwilewicz-Trojaczek, J
Boguradzki, P
Kuliczkowski, K
Sulek, K
Warzocha, K
机构
[1] Med Univ Lodz, Dept Hematol, Copernicus Mem Hosp, PL-93513 Lodz, Poland
[2] Med Univ Lublin, Dept Hematol, Lublin, Poland
[3] Jagiellonian Univ, Dept Hematol, Krakow, Poland
[4] Univ Gdansk, Sch Med, Dept Hematol, PL-80952 Gdansk, Poland
[5] Pomeranian Acad Med, Dept Hematol, Szczecin, Poland
[6] Inst Hematol & Transfusiol, Warsaw, Poland
[7] Med Univ Warsaw, Dept Hematol & Oncol, Warsaw, Poland
[8] Med Acad Wroclaw, Dept Hematol, Wroclaw, Poland
[9] Inst Mil Med, Warsaw, Poland
来源
MEDICAL SCIENCE MONITOR | 2005年 / 11卷 / 10期
关键词
cladribine; chlorambucil; prednisone; CLL; re-treatment; randomized study; long-term follow-up;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: We previously publislied an early report of a randomized, multicenter trial on the efficacy and toxicity of cladribine (2-CdA) + prednisone (P) compared with chlormbucil (Chl) + P ill previously untreated patients with progressive or symptomatic chronic lymphocytic leukemia. Here we present the final report of this study.
引用
收藏
页码:PI71 / PI79
页数:9
相关论文
共 56 条
[1]  
BALCER AM, 1997, BAILLIERE CLIN HAEM, V1, P427
[2]   Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011 [J].
Byrd, JC ;
Rai, K ;
Peterson, BL ;
Appelbaum, FR ;
Morrison, VA ;
Kolitz, JE ;
Shepherd, L ;
Hines, JD ;
Schiffer, CA ;
Larson, RA .
BLOOD, 2005, 105 (01) :49-53
[3]  
Cardoen S, 2001, CLIN CANCER RES, V7, P3559
[4]   Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release [J].
Chandra, J ;
Mansson, E ;
Gogvadze, V ;
Kaufmann, SH ;
Albertioni, F ;
Orrenius, S .
BLOOD, 2002, 99 (02) :655-663
[5]   Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias [J].
Cheson, BD ;
Vena, DA ;
Barrett, J ;
Freidlin, B .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2454-2460
[6]  
CHESON BD, 1989, AM J HEMATOL, V79, P151
[7]   Chlorambucil in indolent chronic lymphocytic leukemia [J].
Dighiero, G ;
Maloum, K ;
Desablens, B ;
Cazin, B ;
Navarro, M ;
Leblay, R ;
Leporrier, M ;
Jaubert, J ;
Lepeu, G ;
Dreyfus, B ;
Binet, JL ;
Travade, P ;
Turpin, FL ;
Tertian, G ;
Bichoffe, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1506-1514
[8]   CONFIDENCE-INTERVALS FOR A BINOMIAL PARAMETER BASED ON MULTISTAGE TESTS [J].
DUFFY, DE ;
SANTNER, TJ .
BIOMETRICS, 1987, 43 (01) :81-93
[9]  
Eichhorst BF, 2003, BLOOD, V102, p109A
[10]  
GREENE MH, 1978, JNCI-J NATL CANCER I, V61, P337